Diapharma
Diapharma Group，Inc。于1997年1月1日在俄亥俄州富兰克林的Pharmacia Hepar公司成立，并开始作为Chromogenix底物和分析的一家美国和加拿大分销商。
在四分之一世纪之前，Chromogenix开发了**个以前名为Kabi Diagnostica的显色底物技术。 Kabi后来与Pharmacia合并。 Diapharma的一些现任员工在Pharmacia的肝素生产厂内的Chromogenix部门工作。
1998年，Diapharma搬到俄亥俄州的西切斯特，现在仍然在那里。 多年来，Diapharma扩大了其产品线，包括来自优良制造商的各种止血，细胞死亡，血小板功能，生态毒理学，分析，试剂，抗体和仪器。
2017年，Diapharma庆祝了二十年的成功。
Diapharma的主要产品领域包括止血，凝血，抗凝，纤维蛋白溶解，血小板功能，细胞死亡和毒理学。 我们出售个体生物试剂，对照，校准品，底物，缺陷等离子体，抗体以及试剂完整生色测定，凝血测定，elisa测试试剂盒和仪器。
Mission Statement
Diapharma Group, Inc. in West Chester, Ohio sellshemostasis, thrombosis,platelet function testing,instrumentation, andapoptosisproducts in the diagnostic and research fields and provides strong technical competence and experience to ensure customer expectations will be met or exceeded.
History
The Diapharma Group, Inc. formed on January 1, 1997 from Pharmacia Hepar, Inc. in Franklin, Ohio, and began as the exclusive US and Canadian distributor of theChromogenix substratesand assays.
Over a quarter-century ago, Chromogenix developed the first chromogenic substrate technology under the former name, Kabi Diagnostica. Kabi later merged with Pharmacia. Some of Diapharma’s current staff worked inside the Chromogenix department within Pharmacia’s heparin manufacturing plant.
In 1998, Diapharma moved to West Chester, Ohio, where it remains today. Over the years, Diapharma expanded its product line to include a variety ofhemostasis,cell death,platelet function,ecotoxicology, assays,reagents,antibodiesandinstrumentsfrom superior manufacturers.
In 2017, Diapharma celebrated twenty years of success.
